|
OMEPRAZOLE DECREASES EFFECTS OF CLOPIDOGREL DUE TO EFFECTS OF CYP LIVER ENZYMES
|
DIGOXIN CONCENTRATION IS INCREASED
|
OMEPRAZOLE & OTHER ANTISECRETORY DRUGS INCREASES ITS ABSORPTION BY THREE FOLDS
|
OMEPRAZOLE & OTHER ANTISECRETORY DRUGS REDUCE ABSORPTION OF THE DRUG
|
OMEPRAZOLE & OTHER ANTISECRETORY DRUGS REDUCE ABSORPTION OF THE DRUG
|
OMEPRAZOLE & OTHER ANTISECRETORY DRUGS REDUCE ABSORPTION OF THE DRUG
|
OMEPRAZOLE & OTHER ANTISECRETORY DRUGS REDUCE ABSORPTION OF THE DRUG
|
CLARITHROMYCIN INCREASES PLASMA CONCENTRATION BY 30% AND MEAN HALF LIFE FROM 1.2 TO 1.6 HRS
|
BENZODIAZEPINES / DIAZEPAM CLEARANCE IS REDUCED BY CO-ADMINISTRATION; HENCE THE DOSE OF DIAZEPAM IS REDUCED BY ONE THIRD
|
BENZODIAZEPINES / DIAZEPAM CLEARANCE IS REDUCED BY CO-ADMINISTRATION; HENCE THE DOSE OF DIAZEPAM IS REDUCED BY ONE THIRD
|
BENZODIAZEPINES / DIAZEPAM CLEARANCE IS REDUCED BY CO-ADMINISTRATION; HENCE THE DOSE OF DIAZEPAM IS REDUCED BY ONE THIRD
|
BENZODIAZEPINES / DIAZEPAM CLEARANCE IS REDUCED BY CO-ADMINISTRATION; HENCE THE DOSE OF DIAZEPAM IS REDUCED BY ONE THIRD
|
BENZODIAZEPINES / DIAZEPAM CLEARANCE IS REDUCED BY CO-ADMINISTRATION; HENCE THE DOSE OF DIAZEPAM IS REDUCED BY ONE THIRD
|
BENZODIAZEPINES / DIAZEPAM CLEARANCE IS REDUCED BY CO-ADMINISTRATION; HENCE THE DOSE OF DIAZEPAM IS REDUCED BY ONE THIRD
|
BENZODIAZEPINES / DIAZEPAM CLEARANCE IS REDUCED BY CO-ADMINISTRATION; HENCE THE DOSE OF DIAZEPAM IS REDUCED BY ONE THIRD
|
BENZODIAZEPINES / DIAZEPAM CLEARANCE IS REDUCED BY CO-ADMINISTRATION; HENCE THE DOSE OF DIAZEPAM IS REDUCED BY ONE THIRD
|
BENZODIAZEPINES / DIAZEPAM CLEARANCE IS REDUCED BY CO-ADMINISTRATION; HENCE THE DOSE OF DIAZEPAM IS REDUCED BY ONE THIRD
|
BENZODIAZEPINES / DIAZEPAM CLEARANCE IS REDUCED BY CO-ADMINISTRATION; HENCE THE DOSE OF DIAZEPAM IS REDUCED BY ONE THIRD
|
BENZODIAZEPINES / DIAZEPAM CLEARANCE IS REDUCED BY CO-ADMINISTRATION; HENCE THE DOSE OF DIAZEPAM IS REDUCED BY ONE THIRD
|
BENZODIAZEPINES / DIAZEPAM CLEARANCE IS REDUCED BY CO-ADMINISTRATION; HENCE THE DOSE OF DIAZEPAM IS REDUCED BY ONE THIRD
|
BENZODIAZEPINES / DIAZEPAM CLEARANCE IS REDUCED BY CO-ADMINISTRATION; HENCE THE DOSE OF DIAZEPAM IS REDUCED BY ONE THIRD
|
BENZODIAZEPINES / DIAZEPAM CLEARANCE IS REDUCED BY CO-ADMINISTRATION; HENCE THE DOSE OF DIAZEPAM IS REDUCED BY ONE THIRD
|
BENZODIAZEPINES / DIAZEPAM CLEARANCE IS REDUCED BY CO-ADMINISTRATION; HENCE THE DOSE OF DIAZEPAM IS REDUCED BY ONE THIRD
|
BENZODIAZEPINES / DIAZEPAM CLEARANCE IS REDUCED BY CO-ADMINISTRATION; HENCE THE DOSE OF DIAZEPAM IS REDUCED BY ONE THIRD
|
OMEPRAZOLE DELAYS ELIMINATION OF THE DRUG
|
OMEPRAZOLE DELAYS ELIMINATION OF THE DRUG
|
OMEPRAZOLE DELAYS ELIMINATION OF THE DRUG
|
OMEPRAZOLE DELAYS ELIMINATION OF THE DRUG
|
OMEPRAZOLE DELAYS ELIMINATION OF THE DRUG
|
OMEPRAZOLE DELAYS ELIMINATION OF THE DRUG
|
OMEPRAZOLE DELAYS ELIMINATION OF THE DRUG
|
OMEPRAZOLE DELAYS ELIMINATION OF THE DRUG
|
OMEPRAZOLE DELAYS ELIMINATION OF THE DRUG
|
OMEPRAZOLE DELAYS ELIMINATION OF THE DRUG
|
OMEPRAZOLE DELAYS ELIMINATION OF THE DRUG
|
ARMODAFINIL CAUSES MODERATE INHIBITION OF CYP2C19 ACTIVITY, HENCE DOSE REDUCTION IS REQUIRED OF OTHER DRUG
|